Koninklijke Philips NV vs Vipshop Holdings Ltd - ADR — how do they compare? Koninklijke Philips NV trades at $24.16 (market cap $23.52B), while Vipshop Holdings Ltd - ADR trades at $12.99 (market cap $6.05B). The key difference: Koninklijke Philips NV is far larger — about 3.9× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays the higher dividend (4.87%). Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Vipshop Holdings Ltd - ADR for 49 Days on average.
| PHG | VIPS | |
|---|---|---|
Market Cap | $23.52B | $6.05B |
Volume | 1,635,069 | 3,719,230 |
Sector | Health | Consumer Cyclical |
52-Week High | $32.91 | $20.29 |
52-Week Low | $23.81 | $12.09 |
Typical Hold Time | 84 Days | 49 Days |
Enterprise Value | $29.87B | $2.87B |
Dividend Yield | 4.17% | 4.87% |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.09, down 0.25% with a bearish technical signal. The company shows improving fundamentals with three consecutive quarterly EPS beats and a return to profitability in 2025 (net income $895M). Recent news highlights innovation in healthcare technology including new product launches and AI partnerships. Valuation metrics appear reasonable with P/E of 18.94 and P/S of 1.18.
PHG presents a mixed outlook with strong operational recovery but technical weakness. The investment case hinges on continued earnings momentum and successful execution of healthcare technology initiatives. Key risks include competitive pressures and potential cybersecurity vulnerabilities following recent hacking incidents. Analyst consensus leans neutral with 36% buy ratings versus 64% hold.
Vipshop Holdings trades at $12.77, showing modest daily gains of 0.16%. The stock presents compelling valuation metrics with a P/E of 4.1 and P/S of 0.4, trading below book value. Recent earnings show mixed performance with Q2 2026 missing expectations, though profitability remains strong with 9.82% net margins. Technical indicators show a bullish overall signal while oscillators remain neutral, with key support at $12.
The investment case centers on deep valuation discounts and strong profitability metrics, though revenue stagnation and consumer headwinds present challenges. Analyst consensus targets $16.17, offering 27% upside potential. Key risks include Chinese consumer sentiment weakness and competitive pressures in the off-price retail sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →